Zdrowie i gospodarka · 20/02/2015

FDA Releases Draft Guidance on Investigating Adverse Reactions from Human Cells, Tissues, and Products

The FDA has made available a draft document outlining requirements for manufacturers of human cells, tissues, and products to report adverse reactions, with the goal of improving safety and transparency in the industry.